Mometasone Furoate NDC 45802-118

NDC codes

FDA NDC Directory

Product NDC (as listed)45802-118Labeler and product segments. Claims need a package NDC.

Product NDC at billing width45802-0118Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
45802-118-46	45802011846	1 BOTTLE in 1 CARTON (45802-118-46) / 60 mL in 1 BOTTLEMarketed from Dec 11, 2008
45802-118-59	45802011859	1 BOTTLE in 1 CARTON (45802-118-59) / 30 mL in 1 BOTTLEMarketed from Feb 2, 2009

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Mometasone Furoate
Generic name (nonproprietary): mometasone furoate
Active ingredients: Mometasone furoate — 1 mg/mL
Dosage form: Solution
Route: Topical
Labeler: Padagis Israel Pharmaceuticals Ltd
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077180
Marketing start: Dec 11, 2008
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 45802-118_fe1488ac-a59e-4396-846f-d97b41ae7924SPL ID fe1488ac-a59e-4396-846f-d97b41ae7924SPL set ID 7296b4a2-f180-4887-a8e0-029f81aec566RxCUI 151030UNII 04201GDN4R
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N445802011846 followed by a unit qualifier and the quantity

Package 45802-0118-46. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 21, 2023.

Indications (excerpt from the label)

Mometasone Furoate Topical Solution 0.1% is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 12 years of age or older. Mometasone Furoate Topical Solution 0.1% is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients ≥ 12 years of age.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 077180

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077180
Product	Strength	Form · route	Labeler	Product NDC
Mometasone Furoate	Mometasone furoate 1 mg/mL	SolutionTopical	Bryant Ranch Prepack	72162-1392
Mometasone Furoate	Mometasone furoate 1 mg/mL	SolutionTopical	Bryant Ranch Prepack	63629-8686
Mometasone Furoate	Mometasone furoate 1 mg/mL	SolutionTopical	Bryant Ranch Prepack	63629-8685